ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
Cardiac flutter | 02.03.02.012 | - | - | Not Available |
Musculoskeletal stiffness | 15.03.05.027 | 0.000453% | | Not Available |
Musculoskeletal discomfort | 15.03.04.001 | - | - | Not Available |
Injection site swelling | 08.02.03.017; 12.07.03.018 | - | - | Not Available |
Infusion site pain | 12.07.05.002; 08.02.05.014 | - | - | Not Available |
Infusion site swelling | 12.07.05.003; 08.02.05.002 | - | - | Not Available |
Infusion site pruritus | 23.03.12.006; 12.07.05.005; 08.02.05.004 | - | - | Not Available |
Nodule | 08.03.05.002 | - | - | Not Available |
Skin burning sensation | 23.03.03.021; 17.02.06.009 | - | - | Not Available |
Haemorrhage | 24.07.01.002 | 0.000907% | | Not Available |
Pharyngeal erythema | 22.04.05.010 | 0.000453% | | Not Available |
Hypoaesthesia oral | 17.02.06.021; 07.05.05.003 | - | - | Not Available |
Paraesthesia oral | 07.05.05.035; 17.02.06.008 | - | - | Not Available |
Graft complication | 12.02.09.009 | - | - | Not Available |
Arcus lipoides | 06.06.03.014 | - | - | Not Available |
Restless legs syndrome | 17.02.07.008; 15.05.03.012 | - | - | Not Available |
Intestinal haemorrhage | 24.07.02.031; 07.12.03.005 | - | - | Not Available |
Angiopathy | 24.03.02.007 | - | - | Not Available |
Infusion site rash | 12.07.05.017; 08.02.05.017; 23.03.13.018 | - | - | Not Available |
Drug resistance | 08.06.01.005 | - | - | Not Available |
Hot flush | 24.03.01.005; 21.02.02.001; 08.01.03.027 | 0.003219% | | |
Eye movement disorder | 17.02.05.025; 06.05.02.008 | - | - | Not Available |
Infestation | 23.11.01.002; 11.09.01.001 | - | - | Not Available |
Inflammation | 10.02.01.089; 08.01.05.007 | - | - | Not Available |
Limb discomfort | 15.03.04.014 | - | - | Not Available |
Ischaemia | 24.04.02.004 | 0.000453% | | Not Available |
Lactation disorder | 21.05.02.004; 18.06.02.003 | - | - | |
Malnutrition | 14.03.02.004 | - | - | Not Available |
Mediastinal disorder | 22.09.03.001 | - | - | Not Available |
Neoplasm progression | 16.16.02.005 | 0.000453% | | Not Available |